Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Hindustan Unilever, Maruti Suzuki India, Coal India, Eicher Motors, Sun Pharmaceutical Industries, and Ambuja Cements, are ...

Indian benchmark indices, BSE Sensex and NSE Nifty, are poised for a weak opening on Thursday after U.S. President Donald ...